Link Pharma Chem Board to Consider Q2 FY27 Results on 3rd Nov'26
Link Pharma Chem Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Link Pharma Chem Board to Consider Q2 FY27 Results on 3rd Nov'26 Link Pharma Chem Ltd has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for designated persons has been closed since 1st Oct'26 and will reopen 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Link Pharma Chem Ltd
- We herewith submit Non Applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015 on Disclosure of related party transactions for the Half year ended on 30th September, 2026. 路 03 Nov 2026
- Unaudited Financial results of the Board meeting held on 3rd November, 2026 路 03 Nov 2026
- Board meeting outcome of Board Meeting held on 3rd November, 2026 路 03 Nov 2026
- Disclosure order Regulation 30 read with Part A of Schedule III of SEBI Regulation 2015 order received from GST Appellate authority, Tribunal , Vadodara FY 2021-22. 路 13 Oct 2026
- Re-appointment of Mr. Satish G. Thakur as Whole Time Director for 3 years. 路 21 Aug 2026
- Re-appointment of Mr. Rishikesh Thakur as Managing Director of the Company for 3 years. 路 21 Aug 2026
- Voting Results pursuant to clause 44(3) of SEBI LODR Regulation,2015 and Scrutinizer''s report for 41st Annual General Meeting of the Company. 路 21 Aug 2026
- Voting Results pursuant to clause 44(3) of SEBI LODR Regulations, 2015, and Scrutinizer''s report for 41st Annual General Meeting of the Company. 路 21 Aug 2026
